Asp125 and Thr130 in transmembrane domain 3 are major sites of α1b-adrenergic receptor antagonist binding
-
- Takahashi Kazuya
- Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences
-
- Hossain Murad
- Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences
-
- Ahmed Maruf
- Pharmacy Department, University of Rajshahi
-
- Bhuiyan Mohiuddin Ahmed
- Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences
-
- Ohnuki Toshio
- Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences
-
- Nagatomo Takafumi
- Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences
書誌事項
- タイトル別名
-
- Asp125 and Thr130 in Transmembrane Domain 3 Are Major Sites of .ALPHA.1b-Adrenergic Receptor Antagonist Binding
- Asp125 and Thr130 in transmembrane domain 3 are major sites of a1b adrenergic receptor antagonist binding
この論文をさがす
抄録
Site-directed mutagenesis was used to investigate the molecular interactions involved in prazosin binding to the human α1b-adrenergic receptor (α1b-AR) receptor. Based on molecular modeling studies, Thr130 and Asp125 in transmembrane region III of the α1b-AR receptor were found to interact with prazosin. Thr130 and Asp125 were mutated to alanine (Ala) and expressed in HEK293 cells. The radioligand [3H]prazosin did not show any binding to Asp125Ala mutant of α1b-AR. Therefore, it was not possible to find any prazosin affinity to the mutant using the radioligand [3H]prazosin. The mutation also abolished phenylephrine-stimulated inositol phosphate (IP) formation of [3H]myo-inositol. On the other hand, the Thr130Ala mutant showed reduced binding affinity for [3H]prazosin (dissociation constant, Kd 674.27 pM versus 90.27 pM for the wild-type receptor) and had reduced affinity for both tamsulosin and prazosin (11-fold and 9-fold, respectively). However, the Thr130Ala mutant receptor retained the ability to stimulate the formation of [3H]myo-inositol. The results provide direct evidence that Asp125 and Thr130 are responsible for the interactions between α1b-AR receptor and radioligand [3H]prazosin as well as tamsulosin.
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 30 (10), 1891-1894, 2007
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679601812992
-
- NII論文ID
- 110006436370
-
- NII書誌ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 8919181
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可